Adherium Limited (ASX:ADR)

Market Cap	5.31M
Revenue (ttm)	964.13K
Net Income (ttm)	-11.33M
Shares Out	758.19M
EPS (ttm)	-0.02
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	17,534
Average Volume	382,240
Open	0.0070
Previous Close	0.0070
Day's Range	0.0070 - 0.0070
52-Week Range	0.0070 - 0.0200
Beta	1.57
RSI	35.86
Earnings Date	May 29, 2025

About Adherium

Adherium Limited develops, manufactures, and supplies digital health technologies that address sub-optimal medication use in chronic diseases in New Zealand, Australia, Europe, and North America. The company offers Hailie Smartinhaler, an asthma and chronic obstructive pulmonary disease medication adherence solution for patients with chronic respiratory diseases. It also provides Bluetooth enabled Hailie sensors, which wrap around patient inhalers and offers real-time feedback to patients; Hailie app; and Hailie portal, as well as Hailie remote...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2001
• Employees: 40
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: ADR

Financial Performance

In 2024, Adherium's revenue was 840,982, a decrease of -73.68% compared to the previous year's 3.20 million. Losses were -10.22 million, 3.72% more than in 2023.